跳至主要内容
临床试验/NCT04077190
NCT04077190已完成不适用

Extension Study of Protocol RC-001b- Safety and Efficacy of Adult Adipose-Derived Stem Cell Injection Into Partial Thickness Rotator Cuff Tears

InGeneron, Inc.4 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2019年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
4
主要终点
Long term efficacy of pain and function through Short Form-36 Shoulder Score health questionnaires

研究概览

简要总结

Extension Study of Protocol RC-001- Safety and Efficacy of Adult Adipose-Derived Stem Cell Injection into Partial Thickness Rotator Cuff Tears. Purpose is to investigate the Long- term safety and efficacy of autologous stem cells in patients with partial thickness rotator cuff tears versus a steroid treatment.

详细描述

The purpose of this investigation is to evaluate the safety and superior effectiveness in functional improvement in patients with partial-thickness rotator cuff tears (PTRCTs) after the administration of a single injection of adipose-derived regenerative cells (ADRCs) into the partial-thickness rotator cuff tear compared to the administration of a single corticosteroid injection into the associated subacromial space.

The ADRC mixture is generated from the Transpose® RT System, a point-of-care solution for extraction of an autologous regenerative cell mixture from the adipose tissue after a same-day limited liposuction procedure. A pilot clinical study was recently completed using an injection of ADRC compared to a corticosteroid injection for treatment of PTRCTs. Results support the initiation of a pivotal study to study the same.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient completed participation in RC-001 (NCT02918136) study
  • Must have the ability to understand and sign a written informed consent form (ICF), which must be obtained prior to initiation of study procedures associated with this trial.

排除标准

  • 未提供

结局指标

主要结局

Long term efficacy of pain and function through Short Form-36 Shoulder Score health questionnaires

时间窗: at 36 months

Short form-36 score compared to baseline (total score = 800)

Long term Safety as indicated through adverse event rate between ADSC and TAU arms

时间窗: at 36 months

Adverse event rate

Long term efficacy of pain and function through ASES Shoulder Score health questionnaires

时间窗: at 36 months

ASES score compared to baseline (total score = 100)

次要结局

  • Long term efficacy will be evaluated through MRIs pre- and post-injection for the therapeutic intent to treat a rotator cuff injury: Percentage improvement in tendon tear size and thickness(at 36 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验